nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOA—Clearance of seratonin—ALDH2—pancreatitis	0.125	0.276	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—pancreatitis	0.0412	0.0909	CbGpPWpGaD
Linezolid—Blindness—Hyoscyamine—pancreatitis	0.0407	0.0745	CcSEcCtD
Linezolid—Thirst—Propantheline—pancreatitis	0.0336	0.0614	CcSEcCtD
Linezolid—MAOA—Oxidative Stress—XDH—pancreatitis	0.0218	0.0481	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.0218	0.048	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.0202	0.0446	CbGpPWpGaD
Linezolid—Disorientation—Hyoscyamine—pancreatitis	0.0183	0.0334	CcSEcCtD
Linezolid—Vision blurred—Propantheline—pancreatitis	0.0181	0.0332	CcSEcCtD
Linezolid—Thirst—Hyoscyamine—pancreatitis	0.0172	0.0314	CcSEcCtD
Linezolid—Hypoglycaemia—Hyoscyamine—pancreatitis	0.0168	0.0307	CcSEcCtD
Linezolid—Hyponatraemia—Hyoscyamine—pancreatitis	0.0164	0.03	CcSEcCtD
Linezolid—MAOB—Tryptophan metabolism—ALDH2—pancreatitis	0.0162	0.0358	CbGpPWpGaD
Linezolid—Dry mouth—Propantheline—pancreatitis	0.016	0.0293	CcSEcCtD
Linezolid—Anaphylactic shock—Propantheline—pancreatitis	0.0157	0.0287	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.0151	0.0333	CbGpPWpGaD
Linezolid—Hypokalaemia—Hyoscyamine—pancreatitis	0.0149	0.0272	CcSEcCtD
Linezolid—Insomnia—Propantheline—pancreatitis	0.0142	0.026	CcSEcCtD
Linezolid—Somnolence—Propantheline—pancreatitis	0.014	0.0255	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.0136	0.0301	CbGpPWpGaD
Linezolid—Constipation—Propantheline—pancreatitis	0.0134	0.0246	CcSEcCtD
Linezolid—Hyperglycaemia—Hyoscyamine—pancreatitis	0.0128	0.0233	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.0127	0.028	CbGpPWpGaD
Linezolid—Urticaria—Propantheline—pancreatitis	0.0125	0.0228	CcSEcCtD
Linezolid—MAOB—Biological oxidations—FDX1—pancreatitis	0.0116	0.0255	CbGpPWpGaD
Linezolid—Asthenia—Propantheline—pancreatitis	0.0113	0.0206	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ADH4—pancreatitis	0.0107	0.0237	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.0106	0.0234	CbGpPWpGaD
Linezolid—Dizziness—Propantheline—pancreatitis	0.0104	0.019	CcSEcCtD
Linezolid—MAOA—Serotonin Transporter Activity—IL1B—pancreatitis	0.0102	0.0224	CbGpPWpGaD
Linezolid—Vomiting—Propantheline—pancreatitis	0.00999	0.0183	CcSEcCtD
Linezolid—Rash—Propantheline—pancreatitis	0.0099	0.0181	CcSEcCtD
Linezolid—Dermatitis—Propantheline—pancreatitis	0.00989	0.0181	CcSEcCtD
Linezolid—Erythema—Hyoscyamine—pancreatitis	0.00985	0.018	CcSEcCtD
Linezolid—Headache—Propantheline—pancreatitis	0.00984	0.018	CcSEcCtD
Linezolid—Dysgeusia—Hyoscyamine—pancreatitis	0.00965	0.0176	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00946	0.0209	CbGpPWpGaD
Linezolid—Nausea—Propantheline—pancreatitis	0.00933	0.0171	CcSEcCtD
Linezolid—Vision blurred—Hyoscyamine—pancreatitis	0.00928	0.017	CcSEcCtD
Linezolid—Angioedema—Hyoscyamine—pancreatitis	0.009	0.0165	CcSEcCtD
Linezolid—Vertigo—Hyoscyamine—pancreatitis	0.00885	0.0162	CcSEcCtD
Linezolid—Convulsion—Hyoscyamine—pancreatitis	0.00854	0.0156	CcSEcCtD
Linezolid—Dry mouth—Hyoscyamine—pancreatitis	0.0082	0.015	CcSEcCtD
Linezolid—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00804	0.0147	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ADH1B—pancreatitis	0.00801	0.0177	CbGpPWpGaD
Linezolid—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00777	0.0142	CcSEcCtD
Linezolid—Insomnia—Hyoscyamine—pancreatitis	0.00727	0.0133	CcSEcCtD
Linezolid—MAOA—Biological oxidations—FDX1—pancreatitis	0.00725	0.016	CbGpPWpGaD
Linezolid—Dyspnoea—Hyoscyamine—pancreatitis	0.00717	0.0131	CcSEcCtD
Linezolid—Somnolence—Hyoscyamine—pancreatitis	0.00715	0.0131	CcSEcCtD
Linezolid—Dyspepsia—Hyoscyamine—pancreatitis	0.00708	0.0129	CcSEcCtD
Linezolid—Fatigue—Hyoscyamine—pancreatitis	0.00693	0.0127	CcSEcCtD
Linezolid—Constipation—Hyoscyamine—pancreatitis	0.00688	0.0126	CcSEcCtD
Linezolid—Pain—Hyoscyamine—pancreatitis	0.00688	0.0126	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ADH4—pancreatitis	0.00674	0.0149	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00667	0.0147	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00657	0.012	CcSEcCtD
Linezolid—Urticaria—Hyoscyamine—pancreatitis	0.00639	0.0117	CcSEcCtD
Linezolid—Abdominal pain—Hyoscyamine—pancreatitis	0.00636	0.0116	CcSEcCtD
Linezolid—Body temperature increased—Hyoscyamine—pancreatitis	0.00636	0.0116	CcSEcCtD
Linezolid—Asthenia—Hyoscyamine—pancreatitis	0.00577	0.0106	CcSEcCtD
Linezolid—MAOB—Tryptophan metabolism—MDM2—pancreatitis	0.00574	0.0127	CbGpPWpGaD
Linezolid—Pruritus—Hyoscyamine—pancreatitis	0.00569	0.0104	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ALDH2—pancreatitis	0.00564	0.0124	CbGpPWpGaD
Linezolid—Diarrhoea—Hyoscyamine—pancreatitis	0.0055	0.0101	CcSEcCtD
Linezolid—Dizziness—Hyoscyamine—pancreatitis	0.00532	0.00972	CcSEcCtD
Linezolid—Vomiting—Hyoscyamine—pancreatitis	0.00511	0.00935	CcSEcCtD
Linezolid—Rash—Hyoscyamine—pancreatitis	0.00507	0.00927	CcSEcCtD
Linezolid—Dermatitis—Hyoscyamine—pancreatitis	0.00506	0.00926	CcSEcCtD
Linezolid—Headache—Hyoscyamine—pancreatitis	0.00504	0.00921	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ADH1B—pancreatitis	0.00503	0.0111	CbGpPWpGaD
Linezolid—Nausea—Hyoscyamine—pancreatitis	0.00478	0.00874	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—TACR1—pancreatitis	0.00419	0.00923	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL13—pancreatitis	0.00371	0.00818	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—ALDH2—pancreatitis	0.00354	0.00781	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—SST—pancreatitis	0.00326	0.00718	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—ALDH2—pancreatitis	0.00314	0.00692	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—EGR1—pancreatitis	0.00281	0.0062	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ALDH2—pancreatitis	0.0024	0.0053	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL10—pancreatitis	0.00232	0.00512	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CTRB2—pancreatitis	0.00228	0.00503	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HTR2A—pancreatitis	0.00205	0.00453	CbGpPWpGaD
Linezolid—MAOB—Metabolism—FDX1—pancreatitis	0.00198	0.00436	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADH4—pancreatitis	0.00184	0.00405	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PRSS1—pancreatitis	0.00173	0.00381	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PNLIP—pancreatitis	0.00164	0.00361	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PRSS3—pancreatitis	0.00164	0.00361	CbGpPWpGaD
Linezolid—MAOB—Metabolism—XDH—pancreatitis	0.00147	0.00324	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CTRB2—pancreatitis	0.00143	0.00315	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADH1B—pancreatitis	0.00137	0.00302	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CXCL8—pancreatitis	0.00127	0.0028	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FDX1—pancreatitis	0.00124	0.00274	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1B—pancreatitis	0.00122	0.00268	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—pancreatitis	0.00121	0.00268	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH4—pancreatitis	0.00115	0.00254	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—MDM2—pancreatitis	0.00111	0.00245	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G1B—pancreatitis	0.00109	0.00241	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PRSS1—pancreatitis	0.00108	0.00239	CbGpPWpGaD
Linezolid—MAOB—Metabolism—A2M—pancreatitis	0.00106	0.00233	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PRSS3—pancreatitis	0.00103	0.00227	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PNLIP—pancreatitis	0.00103	0.00227	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDH2—pancreatitis	0.000965	0.00213	CbGpPWpGaD
Linezolid—MAOA—Metabolism—XDH—pancreatitis	0.000922	0.00203	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—pancreatitis	0.000883	0.00195	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH1B—pancreatitis	0.000859	0.0019	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—MDM2—pancreatitis	0.000852	0.00188	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCG—pancreatitis	0.000731	0.00161	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—pancreatitis	0.000712	0.00157	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G1B—pancreatitis	0.000686	0.00151	CbGpPWpGaD
Linezolid—MAOA—Metabolism—A2M—pancreatitis	0.000662	0.00146	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—HRAS—pancreatitis	0.00061	0.00135	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALDH2—pancreatitis	0.000606	0.00134	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPL—pancreatitis	0.000574	0.00127	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HRAS—pancreatitis	0.000467	0.00103	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCG—pancreatitis	0.000459	0.00101	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARG—pancreatitis	0.000419	0.000924	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—pancreatitis	0.000411	0.000907	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALB—pancreatitis	0.000377	0.000831	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPL—pancreatitis	0.00036	0.000794	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—pancreatitis	0.00033	0.000727	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARG—pancreatitis	0.000263	0.00058	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—pancreatitis	0.000258	0.000569	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALB—pancreatitis	0.000236	0.000522	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—pancreatitis	0.000207	0.000456	CbGpPWpGaD
